SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that it plans to report fourth quarter 2008 financial results on Thursday, February 12, 2009, following the close of market. Ligand’s President and CEO, John L. Higgins, Vice President of Finance and CFO, John Sharp and Vice President of Discovery Research,
